Dr. Ki Chung, MD
Claim this profilePrisma Health Cancer Institute - Eastside
About Ki Chung, MD
Education:
- Earned an MD from Georgetown University School of Medicine in 1999.
- Graduated from the United States Military Academy at West Point in 1995.
Experience:
- Serves as Professor and Chair of the Department of Medicine at the F. Edward Hebert School of Medicine, Uniformed Services University.
- Held the position of Chief of the Department of Medicine at Brooke Army Medical Center, San Antonio.
- Deployed as Chief of the Intensive Care Unit for the 86th Combat Support Hospital in Baghdad, Iraq, in 2008.
- Served as Director of the Joint Combat Casualty Research Team in Bagram, Afghanistan, in 2012.
- Retired as a Colonel in the U.S. Army and currently the Chief Medical Officer of SeaStar Medical.
Area of expertise
Lung Cancer
Ki Chung, MD has run 17 trials for Lung Cancer. Some of their research focus areas include:
Cancer
Ki Chung, MD has run 17 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Prisma Health Cancer Institute - Eastside
Prisma Health Cancer Institute - Faris
Clinical Trials Ki Chung, MD is currently running
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting
1 award
Phase 2
10 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting
2 awards
Phase 3
40 criteria
More about Ki Chung, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 97 trials as a Principal Investigator · 26 Active Clinical Trials
Treatments Ki Chung, MD has experience with
- Pembrolizumab
- Nivolumab
- Carboplatin
- Fluorouracil
- Paclitaxel
- Biospecimen Collection
Breakdown of trials Ki Chung, MD has run
Lung Cancer
Cancer
Pancreatic Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ki Chung, MD specialize in?
Ki Chung, MD focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Ki Chung, MD currently recruiting for clinical trials?
Yes, Ki Chung, MD is currently recruiting for 26 clinical trials in Greenville South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Ki Chung, MD has studied deeply?
Yes, Ki Chung, MD has studied treatments such as Pembrolizumab, Nivolumab, Carboplatin.
What is the best way to schedule an appointment with Ki Chung, MD?
Apply for one of the trials that Ki Chung, MD is conducting.
What is the office address of Ki Chung, MD?
The office of Ki Chung, MD is located at: Prisma Health Cancer Institute - Eastside, Greenville, South Carolina 29615 United States. This is the address for their practice at the Prisma Health Cancer Institute - Eastside.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.